House Delays Hemp Ban Amidst Legislative Push for Regulation

The U.S. House of Representatives passed a bill on Tuesday to extend government funding, granting the hemp industry more time before a restrictive ban takes effect. The bill, known as a continuing resolution, ensures government operations continue until December 11 and succeeded in the House with a 370-48 vote. This measure postpones a federal prohibition on hemp-derived THC products, such as gummies and beverages.

The Senate had previously passed the measure, and it is now set for President Trump’s approval. Industry advocates see this as an opportunity to engage lawmakers in crafting regulations instead of imposing an outright ban. The U.S. Hemp Roundtable expressed its commitment to using this extension to push for a framework that will safeguard consumers, restrict youth access, provide stability for businesses, and maintain lawful hemp product accessibility.

Some products, specifically those with cannabinoids not naturally occurring in Cannabis sativa L., remain restricted starting November 12. This exclusion likely targets certain illicit imports, particularly from China. However, naturally produced cannabinoids such as delta-8 THC and delta-10 THC will remain available in certain retail outlets until at least December 11.

“This extension gives us one additional month, and we intend to make every day count,” stated the U.S. Hemp Roundtable.

Proponents of the initial ban argue that some products, disguised as harmless hemp derivatives, contain high levels of synthetic THC aimed at young consumers. Delaying the ban has grown to be a White House priority. Officials signal a readiness to push for definitive regulation in the upcoming winter session.

In related health news, Panorama Produce initiated a recall of mangoes across several states due to possible salmonella risk. Additionally, President Trump appointed Darrell Scott as tobacco health advisor for the CDC. A significant campaign is also targeting Senator Susan Collins’ previous vote on Justice Brett Kavanaugh, focusing on abortion rights issues.

Other healthcare developments include Pennsylvania’s measles death data disputation by the CDC, Texas facing a Medicaid application backlog, and Michigan’s shortage of healthcare workers.